Emicizumab para el tratamiento primera línea en profilaxis Hemofilia A severa con y sin inhibidores / Emicizumab for first-line treatment in prophylaxis Severe hemophilia A with and without inhibitors
San Salvador; ISSS; nov. 2023.
Non-conventional
in Es
| BRISA
| ID: biblio-1554191
Responsible library:
BR1.1
Main subject:
Immunoglobulin G
/
Antibodies, Bispecific
/
Hemophilia A
Language:
Es
Institution:
Instituto Salvadoreño del Seguro Social (ISSS)
Year:
2023